VKTX filings
Corporate insider profile
Greg Zante Filing Activity
Latest reported as Chief Financial Officer of Viking Therapeutics, Inc. (VKTX).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$710,141.48
- Latest transaction
- Jul 29, 2026
Affiliated corporations
Reported company relationships
Transaction history
